Finder makes money from featured partners, but editorial opinions are our own.

Best ASX pharmaceutical stocks | How to invest

The top performing pharma and medical stocks could be just what the doctor ordered for your portfolio.

Pharmaceutical stocks are companies that research and produce pharmaceutical drugs and medical equipment.

While the industry is dominated by big names like Pfizer, Johnson & Johnson and GlaxoSmithKline — famous for blockbuster drugs netting over $US1 billion in annual sales, like Advair, Lipitor and Zoloft - there's plenty of competition.

There's numerous up-and-comers in the industry offering a spectrum of entry points for Australian investors, like livestock medicine manufacturer Zoetis or Neoleukin Therapeutics, a biopharmaceutical company that targets immunological disorders.

Best ASX pharmaceutical stocks

This is a list of the top pharmaceutical and health technology stocks on the Australian Stock Exchange (ASX), based on their performance so far in 2024 (and over the last 5 years). This list was last updated on 14 June 2024 using TradingView data.

1. Cynata Therapeutics Limited (ASX: CYP)

Year-to-date performance: 138.46%
5-year performance: -74.93%

2. LTR Pharma Limited (ASX: LTP)

Year-to-date performance: 123.19%
5-year performance: 120.00%

3. Cleo Diagnostics Limited (ASX: COV)

Year-to-date performance: 122.86%
5-year performance: 69.57%

4. Race Oncology Limited (ASX: RAC)

Year-to-date performance: 113.10%
5-year performance: 2,834.43%

5. Pharmaust Limited (ASX: PAA)

Year-to-date performance: 95.65%
5-year performance: 462.50%

How to invest in pharmaceutical stocks

There are a few main ways you can invest in or trade pharma stocks:

  1. Buy pharmaceutical stocks directly
  2. Invest in an ETF that includes pharma companies
  3. Trade futures or options

Regardless of how you choose to invest, you'll need to sign up with a broker or trading platform first:

Name Product Price per trade Inactivity fee Asset class International
eToro
Finder AwardExclusive
eToro
$0
US$10 per month if there’s been no log-in for 12 months
ASX shares, Global shares, US shares, ETFs
Yes
Finder exclusive: Get 12 months of investment tracking app Delta PRO for free when you fund your eToro account (T&Cs apply).
CFD service. Capital at risk.
Join the world's biggest social trading network when you trade stocks, commodities and currencies from the one account.
CMC Invest
Finder Award
CMC Invest
$0
$0
ASX shares, Global shares, Options trading, US shares, ETFs
Yes
$0 brokerage on US, UK, Canadian and Japanese markets (FX spreads apply).
Trade over 45,000 shares and ETFs from Australia and 15 major global markets. Plus, buy Aussie shares or ETFs for $0 brokerage up to $1,000 (First buy order of each security, each day - excludes margin loan settled trades).
Moomoo Share Trading
US$0.99
$0
ASX shares, Global shares, US shares, ETFs
Yes
Get 10 free shares + earn 6.8% p.a. on idle cash upon deposit. T&Cs apply.
Trade shares on the ASX, the US markets and buy ETFs with Moomoo. Plus join a community over 20 million investors.
Tiger Brokers
US$2
$0
ASX shares, Global shares, US shares, ETFs
Yes
Finder exclusive: 10 no-brokerage US or ASX market trades in the first 180 days + 7% p.a. on uninvested cash with first deposit of any amount, plus US$30 TSLA + US$30 NVDA shares with deposits up to AU$2000. T&Cs apply.
Trade Australian, US and Asian stocks with no minimum deposit on Tiger Broker’s feature-packed platform.
Webull
Exclusive
Webull
US$0.25
$0
ASX shares, Global shares, Options trading, US shares, ETFs
Yes
Finder exclusive: Get an additional 30 days of $0 brokerage. Get advanced research and trading tools with $0 brokerage and free lvl 2 NASDAQ stock data for 30 days. T&Cs apply.
Trade ASX and US stocks and US options, plus gain access to inbuilt news platforms and educational resources. You can also start trading for less with fractional shares.
loading

Important: The standard brokerage fee displayed is the trade cost for new customers to purchase $1,000 of either Australian or US shares. Where a platform charges different fees for both US and Australian shares we show the lower of the two. Where both CHESS sponsored and custodian shares are offered, we display the cheapest option.

Pharma ETFs

If you'd prefer to invest in an index of pharma companies instead of individual shares, you have a couple of local and international options:

ASX pharma ETFs

  • iShares Global Healthcare ETF (ASX: IXJ)
  • Vaneck Vectors Global Healthcare Leaders ETF (ASX: HLTH)
  • Betashares Digital Health and Telemedicine ETF (ASX: EDOC)

Global pharma ETFs

  • iShares Healthcare Innovation UCITS ETF (LON: HEAL)
  • VanEck Pharmaceutical ETF (NASDAQ: PPH)
  • iShares US Pharmacueticals ETF (NYSEARCA: IHE)
  • Invesco Dynamic Pharmaceuticals ETF (NYSEARCA: PJP)

Why invest in pharmaceutical stocks?

The global pharmaceutical industry is massive — and the US holds the largest slice of the market.

Pharma stocks also have the potential to outperform the broader market. For example, the SPDR S&P Pharmaceuticals ETF has outperformed the S&P 500 since its 2006 inception.

And if the potential for profit isn’t incentive enough, investors also have the opportunity to back potentially groundbreaking, life-saving medicine — medicine that they or a loved one may one day rely on.

Risks of investing in pharmaceuticals

Pharmaceutical stocks present a potentially lucrative investment opportunity but carry significant risks, including competition from generic drugmakers, product patent expirations and the substantial cost of research and development (R&D).

It’s estimated that pharmaceutical companies spend approximately 20% of their revenue on research and development.

Pharma companies also face steep competition from generic drugmakers attempting to undercut brand-name products with cheaper alternatives — especially for drugs with patent expirations on the horizon.

The industry is far from foolproof, and while pharma stocks could be a potentially profitable addition to your portfolio, make sure you understand the risks involved before you invest.

Bottom line

Pharma stocks offer Australian investors the opportunity to back groundbreaking drug research, but competition in this industry has the potential to threaten profits.

To invest in pharmaceutical companies, you’ll need a brokerage account. Compare your platform options to find the brokerage that fits your budget and investment goals needs.

Frequently asked questions

Shannon Terrell's headshot
Writer

Shannon Terrell is a writer for Finder who studied communications and English literature at the University of Toronto. On any given day, you can find her researching everything from equine financing and business loans to student debt refinancing and how to start a trust. She loves hot coffee, the smell of fresh books and discovering new ways to save her pennies. See full bio

More guides on Finder

Ask a Question

You are about to post a question on finder.com.au:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com.au is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder only provides general advice and factual information, so consider your own circumstances, or seek advice before you decide to act on our content. By submitting a question, you're accepting our Terms Of Service and Finder Group Privacy & Cookies Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Go to site